nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—IL3—bone cancer	0.89	1	CbGaD
Amlexanox—S100A12—nose—bone cancer	0.0163	0.341	CbGeAlD
Amlexanox—FGF1—periosteum—bone cancer	0.00672	0.141	CbGeAlD
Amlexanox—FGF1—cartilage tissue—bone cancer	0.00471	0.0988	CbGeAlD
Amlexanox—FGF1—appendage—bone cancer	0.0041	0.0861	CbGeAlD
Amlexanox—IL3—connective tissue—bone cancer	0.00401	0.0841	CbGeAlD
Amlexanox—IL3—bone marrow—bone cancer	0.00267	0.056	CbGeAlD
Amlexanox—S100A13—connective tissue—bone cancer	0.0019	0.0399	CbGeAlD
Amlexanox—S100A12—connective tissue—bone cancer	0.00188	0.0394	CbGeAlD
Amlexanox—S100A12—bone marrow—bone cancer	0.00125	0.0262	CbGeAlD
Amlexanox—FGF1—connective tissue—bone cancer	0.00117	0.0246	CbGeAlD
Amlexanox—PDE4D—tendon—bone cancer	0.00086	0.0181	CbGeAlD
Amlexanox—FGF1—spinal cord—bone cancer	0.000776	0.0163	CbGeAlD
Amlexanox—PDE4B—tendon—bone cancer	0.000454	0.00953	CbGeAlD
Amlexanox—PDE4B—bone marrow—bone cancer	0.00044	0.00923	CbGeAlD
Amlexanox—PDE4B—spinal cord—bone cancer	0.000438	0.00919	CbGeAlD
Amlexanox—PDE4C—GPCR downstream signaling—GRM1—bone cancer	0.000144	0.00232	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—SMO—bone cancer	0.000144	0.00232	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000142	0.00229	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—RGS1—bone cancer	0.000139	0.00224	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—GRM4—bone cancer	0.000139	0.00224	CbGpPWpGaD
Amlexanox—FGF1—Regulation of Actin Cytoskeleton—BRAF—bone cancer	0.000139	0.00224	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—KIT—bone cancer	0.000139	0.00224	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—KIT—bone cancer	0.000138	0.00223	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—GRM4—bone cancer	0.000138	0.00222	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—RGS1—bone cancer	0.000138	0.00222	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—KIT—bone cancer	0.000137	0.00222	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—KIT—bone cancer	0.000137	0.00221	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—PLAU—bone cancer	0.000136	0.0022	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—KIT—bone cancer	0.000135	0.00217	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—GNA11—bone cancer	0.000131	0.00212	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—GRM4—bone cancer	0.000131	0.00212	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—RGS1—bone cancer	0.000131	0.00212	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—GRM1—bone cancer	0.000131	0.00211	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—BRAF—bone cancer	0.00013	0.00209	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—KIT—bone cancer	0.000129	0.00207	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—KIT—bone cancer	0.000129	0.00207	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—KIT—bone cancer	0.000129	0.00207	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000129	0.00207	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—KIT—bone cancer	0.000127	0.00206	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—RGS1—bone cancer	0.000127	0.00205	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—GRM4—bone cancer	0.000127	0.00205	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—KIT—bone cancer	0.000126	0.00204	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—KIT—bone cancer	0.000126	0.00203	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—GRM1—bone cancer	0.000125	0.00202	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—RGS1—bone cancer	0.000125	0.00201	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—GRM4—bone cancer	0.000125	0.00201	CbGpPWpGaD
Amlexanox—FGF1—Constitutive PI3K/AKT Signaling in Cancer—EGFR—bone cancer	0.000123	0.00199	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—MDM2—bone cancer	0.000121	0.00196	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—BRAF—bone cancer	0.000121	0.00195	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—GRM1—bone cancer	0.00012	0.00194	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000119	0.00193	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—GRM1—bone cancer	0.000119	0.00192	CbGpPWpGaD
Amlexanox—PDE4D—Myometrial Relaxation and Contraction Pathways—JUN—bone cancer	0.000119	0.00192	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—KIT—bone cancer	0.000119	0.00192	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—MDM2—bone cancer	0.000116	0.00188	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—RGS1—bone cancer	0.000116	0.00186	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—GRM4—bone cancer	0.000116	0.00186	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—MDM2—bone cancer	0.000114	0.00185	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—KIT—bone cancer	0.000114	0.00184	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—GRM1—bone cancer	0.000114	0.00184	CbGpPWpGaD
Amlexanox—IL3—Immune System—ATF1—bone cancer	0.000112	0.0018	CbGpPWpGaD
Amlexanox—FGF1—PI-3K cascade—EGFR—bone cancer	0.000111	0.00179	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—GRM1—bone cancer	0.00011	0.00178	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—MDM2—bone cancer	0.000109	0.00176	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—MDM2—bone cancer	0.000109	0.00175	CbGpPWpGaD
Amlexanox—FGF1—PI3K/AKT activation—EGFR—bone cancer	0.000108	0.00175	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—GRM1—bone cancer	0.000108	0.00175	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—MDM2—bone cancer	0.000108	0.00175	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—MDM2—bone cancer	0.000108	0.00174	CbGpPWpGaD
Amlexanox—FGF1—GAB1 signalosome—EGFR—bone cancer	0.000108	0.00174	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—BRAF—bone cancer	0.000107	0.00173	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—MDM2—bone cancer	0.000106	0.00171	CbGpPWpGaD
Amlexanox—FGF1—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—bone cancer	0.000105	0.0017	CbGpPWpGaD
Amlexanox—PDE4B—Myometrial Relaxation and Contraction Pathways—JUN—bone cancer	0.000105	0.00169	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—MMP9—bone cancer	0.000103	0.00166	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—MDM2—bone cancer	0.000101	0.00163	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—MDM2—bone cancer	0.000101	0.00163	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—MDM2—bone cancer	0.000101	0.00163	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—MDM2—bone cancer	0.0001	0.00162	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—GRM1—bone cancer	0.0001	0.00162	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—MDM2—bone cancer	9.95e-05	0.0016	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—MDM2—bone cancer	9.9e-05	0.0016	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	9.53e-05	0.00154	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—MDM2—bone cancer	9.37e-05	0.00151	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—GNA11—bone cancer	9.27e-05	0.0015	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—SMO—bone cancer	9.21e-05	0.00149	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	9.19e-05	0.00148	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—MDM2—bone cancer	8.97e-05	0.00145	CbGpPWpGaD
Amlexanox—S100A12—Immune System—ATF1—bone cancer	8.95e-05	0.00144	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—GRM4—bone cancer	8.9e-05	0.00144	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—RGS1—bone cancer	8.9e-05	0.00144	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—JUN—bone cancer	8.8e-05	0.00142	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—ATF1—bone cancer	8.78e-05	0.00142	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—KIT—bone cancer	8.76e-05	0.00141	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—KIT—bone cancer	8.74e-05	0.00141	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL3—bone cancer	8.73e-05	0.00141	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—SMO—bone cancer	8.49e-05	0.00137	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—GNA11—bone cancer	8.42e-05	0.00136	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—IL3—bone cancer	8.41e-05	0.00136	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—EGFR—bone cancer	8.3e-05	0.00134	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	8.28e-05	0.00134	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—BRAF—bone cancer	8.23e-05	0.00133	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—GNA11—bone cancer	8.07e-05	0.0013	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—SMO—bone cancer	8.02e-05	0.00129	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—EGFR—bone cancer	7.94e-05	0.00128	CbGpPWpGaD
Amlexanox—FGF1—Regulation of Actin Cytoskeleton—EGFR—bone cancer	7.94e-05	0.00128	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—EGFR—bone cancer	7.82e-05	0.00126	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—GNA11—bone cancer	7.76e-05	0.00125	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—GRM4—bone cancer	7.75e-05	0.00125	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—RGS1—bone cancer	7.75e-05	0.00125	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—GRM1—bone cancer	7.72e-05	0.00125	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—GNA11—bone cancer	7.68e-05	0.00124	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—IL3—bone cancer	7.63e-05	0.00123	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—SMO—bone cancer	7.63e-05	0.00123	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—EGFR—bone cancer	7.47e-05	0.0012	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—EGFR—bone cancer	7.43e-05	0.0012	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—EGFR—bone cancer	7.39e-05	0.00119	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—GRM4—bone cancer	7.38e-05	0.00119	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—RGS1—bone cancer	7.38e-05	0.00119	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—EGFR—bone cancer	7.36e-05	0.00119	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—GNA11—bone cancer	7.33e-05	0.00118	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—IL3—bone cancer	7.32e-05	0.00118	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—EGFR—bone cancer	7.25e-05	0.00117	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—ATF1—bone cancer	7.22e-05	0.00116	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—GNA11—bone cancer	7.11e-05	0.00115	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—SMO—bone cancer	7.06e-05	0.00114	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—GNA11—bone cancer	6.98e-05	0.00113	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—IL3—bone cancer	6.97e-05	0.00112	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—EGFR—bone cancer	6.92e-05	0.00112	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—EGFR—bone cancer	6.92e-05	0.00112	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—EGFR—bone cancer	6.92e-05	0.00112	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—MDM2—bone cancer	6.9e-05	0.00111	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—MDM2—bone cancer	6.89e-05	0.00111	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—EGFR—bone cancer	6.86e-05	0.00111	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—RGS1—bone cancer	6.83e-05	0.0011	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—GRM4—bone cancer	6.83e-05	0.0011	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—EGFR—bone cancer	6.8e-05	0.0011	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—EGFR—bone cancer	6.77e-05	0.00109	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—GRM1—bone cancer	6.72e-05	0.00108	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IL3—bone cancer	6.65e-05	0.00107	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	6.51e-05	0.00105	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—GNA11—bone cancer	6.46e-05	0.00104	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—IL3—bone cancer	6.45e-05	0.00104	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—EGFR—bone cancer	6.41e-05	0.00103	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—GRM1—bone cancer	6.4e-05	0.00103	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—RGS1—bone cancer	6.37e-05	0.00103	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—GRM4—bone cancer	6.37e-05	0.00103	CbGpPWpGaD
Amlexanox—IL3—Immune System—KIT—bone cancer	6.35e-05	0.00103	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IL3—bone cancer	6.33e-05	0.00102	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—EGFR—bone cancer	6.13e-05	0.000989	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TGFBR2—bone cancer	6.02e-05	0.000971	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—JUN—bone cancer	5.99e-05	0.000966	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—GRM1—bone cancer	5.92e-05	0.000955	CbGpPWpGaD
Amlexanox—FGF1—Disease—ENO2—bone cancer	5.86e-05	0.000945	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL3—bone cancer	5.85e-05	0.000944	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IGF1R—bone cancer	5.66e-05	0.000914	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—GRM1—bone cancer	5.52e-05	0.00089	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—TP53—bone cancer	5.48e-05	0.000883	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	5.47e-05	0.000882	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—SMO—bone cancer	5.44e-05	0.000877	CbGpPWpGaD
Amlexanox—FGF1—Disease—DHFR—bone cancer	5.43e-05	0.000877	CbGpPWpGaD
Amlexanox—FGF1—Immune System—ATF1—bone cancer	5.11e-05	0.000825	CbGpPWpGaD
Amlexanox—S100A12—Immune System—KIT—bone cancer	5.09e-05	0.000821	CbGpPWpGaD
Amlexanox—IL3—Immune System—MDM2—bone cancer	5e-05	0.000807	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—KIT—bone cancer	5e-05	0.000806	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL3—bone cancer	4.99e-05	0.000804	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—GNA11—bone cancer	4.97e-05	0.000803	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—KIT—bone cancer	4.8e-05	0.000774	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SMO—bone cancer	4.73e-05	0.000764	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—EGFR—bone cancer	4.71e-05	0.000761	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—EGFR—bone cancer	4.71e-05	0.000759	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—ATF1—bone cancer	4.62e-05	0.000746	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL3—bone cancer	4.51e-05	0.000728	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SMO—bone cancer	4.51e-05	0.000727	CbGpPWpGaD
Amlexanox—IL3—Immune System—JUN—bone cancer	4.35e-05	0.000702	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—GNA11—bone cancer	4.33e-05	0.000699	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SMO—bone cancer	4.17e-05	0.000673	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—GNA11—bone cancer	4.12e-05	0.000665	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—KIT—bone cancer	4.11e-05	0.000663	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—ATF1—bone cancer	4.03e-05	0.000649	CbGpPWpGaD
Amlexanox—S100A12—Immune System—MDM2—bone cancer	4.01e-05	0.000647	CbGpPWpGaD
Amlexanox—FGF1—Disease—TGFBR2—bone cancer	3.94e-05	0.000635	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—MDM2—bone cancer	3.94e-05	0.000635	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL3—bone cancer	3.93e-05	0.000633	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SMO—bone cancer	3.89e-05	0.000627	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—BRAF—bone cancer	3.86e-05	0.000623	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TGFBR2—bone cancer	3.86e-05	0.000622	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—ATF1—bone cancer	3.83e-05	0.000618	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—GNA11—bone cancer	3.81e-05	0.000615	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—MDM2—bone cancer	3.78e-05	0.00061	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—EGFR—bone cancer	3.74e-05	0.000604	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL3—bone cancer	3.74e-05	0.000603	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IGF1R—bone cancer	3.63e-05	0.000585	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—GNA11—bone cancer	3.56e-05	0.000574	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—ATF1—bone cancer	3.55e-05	0.000572	CbGpPWpGaD
Amlexanox—S100A12—Immune System—JUN—bone cancer	3.49e-05	0.000562	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL3—bone cancer	3.46e-05	0.000558	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—JUN—bone cancer	3.42e-05	0.000552	CbGpPWpGaD
Amlexanox—IL3—Immune System—EGFR—bone cancer	3.42e-05	0.000552	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TGFBR2—bone cancer	3.36e-05	0.000542	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—ATF1—bone cancer	3.31e-05	0.000533	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MDM2—bone cancer	3.24e-05	0.000522	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL3—bone cancer	3.22e-05	0.00052	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TGFBR2—bone cancer	3.2e-05	0.000516	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IGF1R—bone cancer	3.16e-05	0.00051	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IGF1R—bone cancer	3.01e-05	0.000485	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TGFBR2—bone cancer	2.96e-05	0.000477	CbGpPWpGaD
Amlexanox—FGF1—Immune System—KIT—bone cancer	2.91e-05	0.000469	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—JUN—bone cancer	2.81e-05	0.000454	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IGF1R—bone cancer	2.78e-05	0.000449	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TGFBR2—bone cancer	2.76e-05	0.000445	CbGpPWpGaD
Amlexanox—S100A12—Immune System—EGFR—bone cancer	2.74e-05	0.000442	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MMP9—bone cancer	2.74e-05	0.000441	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—EGFR—bone cancer	2.69e-05	0.000434	CbGpPWpGaD
Amlexanox—FGF1—Disease—KIT—bone cancer	2.69e-05	0.000433	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—KIT—bone cancer	2.63e-05	0.000425	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IGF1R—bone cancer	2.59e-05	0.000419	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—EGFR—bone cancer	2.58e-05	0.000417	CbGpPWpGaD
Amlexanox—FGF1—Disease—BRAF—bone cancer	2.53e-05	0.000407	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—BRAF—bone cancer	2.47e-05	0.000399	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—EGFR—bone cancer	2.4e-05	0.000387	CbGpPWpGaD
Amlexanox—FGF1—Immune System—MDM2—bone cancer	2.29e-05	0.00037	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—KIT—bone cancer	2.29e-05	0.00037	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—EGFR—bone cancer	2.21e-05	0.000357	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—KIT—bone cancer	2.18e-05	0.000352	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—BRAF—bone cancer	2.15e-05	0.000347	CbGpPWpGaD
Amlexanox—FGF1—Disease—MDM2—bone cancer	2.12e-05	0.000341	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—EGFR—bone cancer	2.09e-05	0.000337	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MDM2—bone cancer	2.07e-05	0.000334	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—BRAF—bone cancer	2.05e-05	0.000331	CbGpPWpGaD
Amlexanox—FGF1—Disease—PTGS2—bone cancer	2.04e-05	0.000329	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—KIT—bone cancer	2.02e-05	0.000326	CbGpPWpGaD
Amlexanox—FGF1—Immune System—JUN—bone cancer	1.99e-05	0.000321	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—EGFR—bone cancer	1.99e-05	0.000321	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—BRAF—bone cancer	1.9e-05	0.000306	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—KIT—bone cancer	1.88e-05	0.000304	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TP53—bone cancer	1.86e-05	0.000299	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—EGFR—bone cancer	1.84e-05	0.000297	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MDM2—bone cancer	1.8e-05	0.000291	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—JUN—bone cancer	1.8e-05	0.000291	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—BRAF—bone cancer	1.77e-05	0.000285	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MMP9—bone cancer	1.75e-05	0.000283	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MDM2—bone cancer	1.72e-05	0.000277	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MDM2—bone cancer	1.59e-05	0.000256	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—JUN—bone cancer	1.57e-05	0.000253	CbGpPWpGaD
Amlexanox—FGF1—Immune System—EGFR—bone cancer	1.57e-05	0.000253	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MMP9—bone cancer	1.53e-05	0.000246	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—JUN—bone cancer	1.49e-05	0.000241	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MDM2—bone cancer	1.48e-05	0.000239	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MMP9—bone cancer	1.45e-05	0.000234	CbGpPWpGaD
Amlexanox—FGF1—Disease—EGFR—bone cancer	1.45e-05	0.000233	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—EGFR—bone cancer	1.42e-05	0.000229	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—JUN—bone cancer	1.38e-05	0.000223	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MMP9—bone cancer	1.34e-05	0.000217	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—JUN—bone cancer	1.29e-05	0.000208	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MMP9—bone cancer	1.25e-05	0.000202	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—EGFR—bone cancer	1.23e-05	0.000199	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TP53—bone cancer	1.19e-05	0.000192	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—EGFR—bone cancer	1.17e-05	0.000189	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—EGFR—bone cancer	1.09e-05	0.000175	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TP53—bone cancer	1.04e-05	0.000167	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—EGFR—bone cancer	1.01e-05	0.000163	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TP53—bone cancer	9.86e-06	0.000159	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TP53—bone cancer	9.12e-06	0.000147	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TP53—bone cancer	8.5e-06	0.000137	CbGpPWpGaD
